Home/Filings/4/0001144204-12-065878
4//SEC Filing

Leventhal Mark S 4

Accession 0001144204-12-065878

CIK 0000868278other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 6:00 PM ET

Size

8.5 KB

Accession

0001144204-12-065878

Insider Transaction Report

Form 4
Period: 2012-11-28
Transactions
  • Purchase

    Common Stock, par value $0.0005

    2012-11-28$1.42/sh+47,300$67,16647,300 total(indirect: By Foundation)
  • Purchase

    Common Stock, par value $0.0005

    2012-11-29$1.60/sh+102,700$164,320150,000 total(indirect: By Foundation)
Holdings
  • Common Stock, par value $0.0005

    290,195
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.4193 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.599 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1
  • filerCIK 0001459632

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 6:00 PM ET
Size
8.5 KB